PVLA
Palvella Therapeutics
PVLA
PVLA
98 hedge funds and large institutions have $93M invested in Palvella Therapeutics in 2018 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 36 increasing their positions, 28 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
53% less capital invested
Capital invested by funds: $199M → $93M (-$106M)
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $84K
Holders
98
Holding in Top 10
1
Calls
–
Puts
$84K
Top Buyers
| 1 | +$4.94M | |
| 2 | +$1.92M | |
| 3 | +$1.66M | |
| 4 |
Renaissance Technologies
New York
|
+$1.6M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$909K |
Top Sellers
| 1 | -$13.8M | |
| 2 | -$3.53M | |
| 3 | -$2.08M | |
| 4 |
ACM
Aquilo Capital Management
San Francisco,
California
|
-$2.03M |
| 5 |
Baird Financial Group
Milwaukee,
Wisconsin
|
-$933K |